UPSHER SMITH LABS FDA Approval ANDA 075135

ANDA 075135

UPSHER SMITH LABS

FDA Drug Application

Application #075135

Documents

Letter1999-12-02
Letter2000-02-01
Review1999-05-28
Review2002-10-29
Review2002-10-29
Review2002-10-29
Review2002-10-29
Other Important Information from FDA2005-08-01
Letter1998-04-30
Letter1998-04-30
Letter1999-09-24
Label1998-04-30
Review2002-10-29
Review2002-10-29
Review2002-10-29
Medication Guide2009-11-20

Application Sponsors

ANDA 075135UPSHER SMITH LABS

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORAL200MG0PACERONEAMIODARONE HYDROCHLORIDE
002TABLET;ORAL100MG0PACERONEAMIODARONE HYDROCHLORIDE
003TABLET;ORAL400MG0PACERONEAMIODARONE HYDROCHLORIDE

FDA Submissions

ORIG1AP1998-04-30
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1999-12-02
LABELING; LabelingSUPPL3AP1999-09-24
BIOEQUIV; BioequivalenceSUPPL4AP2000-02-01
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2000-04-12
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2000-04-12
LABELING; LabelingSUPPL7AP2000-04-12
LABELING; LabelingSUPPL8AP2002-08-20
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2002-12-19
LABELING; LabelingSUPPL11AP2005-04-12
LABELING; LabelingSUPPL13AP2003-09-24
LABELING; LabelingSUPPL16AP2004-01-05
LABELING; LabelingSUPPL17AP2004-10-04
LABELING; LabelingSUPPL18AP2006-02-13
LABELING; LabelingSUPPL25AP2006-04-04
LABELING; LabelingSUPPL26AP2019-11-01
LABELING; LabelingSUPPL27AP2019-11-01
LABELING; LabelingSUPPL34AP2007-11-16
LABELING; LabelingSUPPL35AP2019-11-01
LABELING; LabelingSUPPL39AP2009-04-28
LABELING; LabelingSUPPL40AP2009-12-01
LABELING; LabelingSUPPL41AP2010-11-30
LABELING; LabelingSUPPL43AP2013-06-17
LABELING; LabelingSUPPL44AP2013-06-17
LABELING; LabelingSUPPL45AP2015-08-13STANDARD
LABELING; LabelingSUPPL46AP2015-08-13STANDARD
LABELING; LabelingSUPPL47AP2015-08-13STANDARD
LABELING; LabelingSUPPL48AP2015-08-13STANDARD
LABELING; LabelingSUPPL49AP2019-11-01STANDARD
LABELING; LabelingSUPPL51AP2019-11-01STANDARD
LABELING; LabelingSUPPL52AP2019-11-01STANDARD
LABELING; LabelingSUPPL54AP2019-11-01STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null13
SUPPL9Null0
SUPPL26Null15
SUPPL27Null15
SUPPL35Null15
SUPPL40Null8
SUPPL41Null7
SUPPL43Null15
SUPPL44Null15
SUPPL45Null15
SUPPL46Null15
SUPPL47Null7
SUPPL48Null7
SUPPL49Null7
SUPPL51Null7
SUPPL52Null7
SUPPL54Null7

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

UPSHER SMITH LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75135
            [companyName] => UPSHER SMITH LABS
            [docInserts] => ["Medication Guide","http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/ucm088668.pdf"]
            [products] => [{"drugName":"PACERONE","activeIngredients":"AMIODARONE HYDROCHLORIDE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"PACERONE","activeIngredients":"AMIODARONE HYDROCHLORIDE","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"04\/30\/1998","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/anda\\\/98\\\/75135ap_appltr_prntlbl_chemr.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"PACERONE","submission":"AMIODARONE HYDROCHLORIDE","actionType":"200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"PACERONE","submission":"AMIODARONE HYDROCHLORIDE","actionType":"100MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1998-04-30
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.